Aumenta tu energa y rendimiento deportivo
BPC-157 holds significant promise for supporting gastrointestinal health, particularly by protecting the stomach lining and accelerating the healing of stomach ulcers
For patients who have established atherosclerotic cardiovascular disease or high-risk indicators, established kidney disease, or heart failure, a GLP-1 RA or a sodium-glucose cotransporter-2 (SGLT2) inhibitor demonstrated cardiovascular disease benefit is recommended
Summary: There is currently no established causal link between Ozempic (semaglutide) and hearing loss according to MHRA, EMA, or official product literature
Suitable for face and body use
3 rd November 2025 How California Prunes are proving a powerful ally to a GLP-1 diet Prunes are being praised as the ideal ally for consumers using weight loss drugs, thanks to their nutrient-dense profile and natural fibre